SCD5 expression correlates with prognosis and response to neoadjuvant chemotherapy in breast cancer von Zhao, Weipeng, Sun, Linlin, Li, Xichuan, Wang, Jun, Zhu, Ye, Jia, Yan, Tong, Zhongsheng

Volltext

Cardiac safety analysis of anti-HER2-targeted therapy in early breast cancer von Zhang, Li, Wang, Yan, Meng, Wenjing, Zhao, Weipeng, Tong, Zhongsheng

Volltext

Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple‐negative breast cancer von Hu, Xichun, Zhang, Jian, Xu, Binghe, Jiang, Zefei, Ragaz, Joseph, Tong, Zhongsheng, Zhang, Qingyuan, Wang, Xiaojia, Feng, Jifeng, Pang, Danmei, Fan, Minhao, Li, Jin, Wang, Biyun, Wang, Zhonghua, Zhang, Qunling, Sun, Si, Liao, Chunmei

Volltext

A phase Ib study of camrelizumab in combination with apatinib and fuzuloparib in patients with recurrent or metastatic triple-negative breast cancer von Zhang, Qingyuan, Shao, Bin, Tong, Zhongsheng, Ouyang, Quchang, Wang, Yuting, Xu, Guoying, Li, Shaorong, Li, Huiping

Volltext

MiR-223-3p targeting epithelial cell transforming sequence 2 oncogene inhibits the activity, apoptosis, invasion and migration of MDA-MB-468 breast cancer cells von Wang, Xiaorui, Tong, Zhongsheng, Liu, Hong

Volltext

Single-cell sequencing deciphers a convergent evolution of copy number alterations from primary to circulating tumor cells von Gao, Yan, Ni, Xiaohui, Guo, Hua, Su, Zhe, Ba, Yi, Tong, Zhongsheng, Guo, Zhi, Yao, Xin, Chen, Xixi, Yin, Jian, Yan, Zhao, Guo, Lin, Liu, Ying, Bai, Fan, Xie, X Sunney, Zhang, Ning

Volltext

Receptor conversion impacts outcomes of different molecular subtypes of primary breast cancer von Zhao, Weipeng, Sun, Linlin, Dong, Guolei, Wang, Xiaorui, Jia, Yan, Tong, Zhongsheng

Volltext

Landscape of somatic alterations in large-scale solid tumors from an Asian population von Wu, Liqun, Yao, Herui, Chen, Hui, Wang, Aodi, Guo, Kun, Gou, Wenli, Yu, Yanfei, Li, Xiang, Yao, Ming, Yuan, Shaohua, Pang, Fei, Hu, Jinwei, Chen, Lijuan, Liu, Wenjin, Yao, Jicheng, Zhang, Shuirong, Dong, Xiaowei, Wang, Weifeng, Hu, Jing, Ling, Qi, Ding, Songming, Wei, Yan, Li, Qiang, Cao, Weichun, Wang, Shuang, Di, Yang, Feng, Feiling, Zhao, Gang, Zhang, Jian, Huang, Ling, Xu, Jia, Yan, Wangjun, Tong, Zhongsheng, Jiang, Da, Ji, Tao, Li, Qiao, Xu, Ling, He, Huiying, Shang, Liang, Liu, Jin, Wang, Kefeng, Wu, Duoguang, Shen, Jingnan, Liu, Ye, Zhang, Ting, Liang, Chaojie, Wang, Yusheng, Shang, Yanhong, Guo, Jianji, Liang, Guanbiao, Xu, Shifeng, Liu, Junfeng, Wang, Kai, Wang, Minghui

Volltext

Lerociclib plus fulvestrant in patients with HR+/HER2− locally advanced or metastatic breast cancer who have progressed on prior endocrine therapy: LEONARDA-1 a phase III randomize... von Xu, Binghe, Zhang, Qingyuan, Luo, Yang, Tong, Zhongsheng, Sun, Tao, Shan, Changping, Liu, Xinlan, Yao, Yumin, Zhao, Bing, Wang, Shusen, Zeng, Xiaohua, Hu, Changlu, Yan, Xi, Wang, Xiaojia, Jia, Hongyan, Chen, Zhendong, Qiu, Fuming, Wu, Xinhong, Zhang, Deyong, Li, Tong

Volltext

Application progress of artificial intelligence in tumor diagnosis and treatment von Sun, Fan, Zhang, Li, Tong, Zhongsheng

Volltext

Whole‐genome circulating tumor DNA methylation landscape reveals sensitive biomarkers of breast cancer von Hai, Luo, Li, Lingyu, Liu, Zongzhi, Tong, Zhongsheng, Sun, Yingli

Volltext

Randomized Trial of Lapatinib Versus Placebo Added to Paclitaxel in the Treatment of Human Epidermal Growth Factor Receptor 2–Overexpressing Metastatic Breast Cancer von Guan, Zhongzhen, Xu, Binghe, DeSilvio, Michelle L, Shen, Zhenzhou, Arpornwirat, Wichit, Tong, Zhongsheng, Lorvidhaya, Vicharn, Jiang, Zefei, Yang, Junlan, Makhson, Anatoly, Leung, Wai Lim, Russo, Mark W, Newstat, Beth, Wang, Li, Chen, George, Oliva, Cristina, Gomez, Henry

Volltext

Clinicopathological Features and Prognosis of Gastrointestinal Metastases From Breast Carcinoma: A Clinicopathological Study of 22 Patients von Wang, Shuling, Li, Weidong, Li, Shuai, Liu, Xiaodong, Zhang, Li, Hao, Chunfang, Meng, Wenjing, Zhao, Weipeng, Tong, Zhongsheng

Volltext

HER2-targeting antibody drug conjugate FS-1502 in HER2-expressing metastatic breast cancer: a phase 1a/1b trial von Li, Qiao, Cheng, Ying, Tong, Zhongsheng, Liu, Yunjiang, Wang, Xian, Yan, Min, Chang, Jianhua, Wang, Shusen, Du, Caiwen, Li, Liang, Wu, Chunjiao, Wang, Mingxia, Wang, Zhuo, Wu, Zhuli, Wang, Xingli, Jin, Yongli, Diao, Lei, Sun, Yi, Zhang, Yongjiao, Hui, Ai-Min, Xu, Binghe

Volltext

Real‐world data for the renal safety of abemaciclib combined with bisphosphonate in HR+/HER2− advanced breast cancer von Hao, Chunfang, Bai, Xuedong, Zhang, Jie, Meng, Wenjing, Tong, Zhongsheng

Volltext

A non-inferiority, phase III trial of gemcitabine plus capecitabine versus gemcitabine plus carboplatin as first-line therapy and tumor-infiltrating lymphocytes as a prognostic bio... von Liu, Xiaodong, Zhao, Weipeng, Jia, Yongsheng, Shi, Yehui, Wang, Xu, Li, Shufen, Zhang, Pin, Wang, Chen, Hao, Chunfang, Tong, Zhongsheng

Volltext

Comparison of the clinical and prognostic features of primary breast sarcomas and malignant phyllodes tumor von Wang, Fang, Jia, Yan, Tong, Zhongsheng

Volltext

PD-1 inhibitor sintilimab treated patients with metastatic triple-negative breast cancer von Jia, Yan, Zhang, Jie, Shi, Yehui, Dong, Guolei, Guo, Xiaojing, Tong, Zhongsheng

Volltext

De novo metastatic breast cancer: Subgroup analysis of molecular subtypes and prognosis von Zhang, Li, Li, Zhijun, Zhang, Jie, Wu, Yansheng, Zhu, Yuying, Tong, Zhongsheng

Volltext

ZDHHC9: a promising therapeutic target for triple-negative breast cancer through immune modulation and immune checkpoint blockade resistance von Xu, Chao, Xie, Yongjie, Xie, Peng, Li, Jianming, Tong, Zhongsheng, Yang, Yanfang

Volltext